Inflammasome-Primed Neutrophils Aggravate Atherosclerosis in Cigarette Smoking
Authors:
- 10 June 2026
- journal article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 139 (3)
Abstract
BACKGROUND: Cigarette smoking (CS) is a major risk factor for cardiovascular disease through chronic inflammation. While its pulmonary effects are well established, the mechanisms linking lung inflammation to vascular injury remain unclear. Because neutrophils are early responders to CS-induced inflammation, we hypothesized that they drive systemic myelopoiesis and vascular inflammation via alarmin release. METHODS: Wild-type mice were exposed to inhaled CS or orally administered cigarette smoke extract. Immune cell composition in lung, bronchoalveolar lavage fluid, blood, spleen, and bone marrow was assessed by flow cytometry. Hematopoietic stem and progenitor cell proliferation, reactive oxygen species production, and S100A8/A9 (S100 calcium-binding protein A8/A9) release were quantified. Atherosclerosis progression was evaluated in Ldlr −/− (low-density lipoprotein receptor-deficient) mice fed a Western diet and treated with cigarette smoke extract. To define the role of neutrophil-derived S100A8/A9, bone marrow transplantation was performed using S100a9 −/− or wild-type donors. RESULTS: CS exposure increased circulating monocytes and neutrophils through enhanced bone marrow myelopoiesis and elevated reactive oxygen species-dependent S100A8/A9 release. Oral cigarette smoke extract reproduced these effects, indicating direct activation of neutrophils independent of pulmonary inflammation or lipid changes. In Ldlr −/− mice, cigarette smoke extract accelerated atherosclerosis by promoting infiltration of inflammasome-primed neutrophils, increasing IL-1β (interleukin 1 beta) release, and impairing macrophage efferocytosis. Hematopoietic S100a9 deletion normalized myelopoiesis and reduced vascular inflammation and plaque burden. CONCLUSIONS: Ingested CS components directly activate neutrophils to release S100A8/A9, triggering myelopoiesis and vascular inflammation. These findings reveal that tobacco’s cardiovascular toxicity extends beyond inhalation, implicating oral exposure as a driver of systemic inflammation and atherogenesis.Keywords
This publication has 67 references indexed in Scilit:
- Release of IL‐1β and IL‐18 in human primary bronchial epithelial cells exposed to cigarette smoke is independent of NLRP3European Journal of Immunology, 2024
- Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary diseaseCell Reports, 2023
- PM2.5 induces endothelial dysfunction via activating NLRP3 inflammasomeEnvironmental Toxicology, 2021
- CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic ImplicationsCurrent Atherosclerosis Reports, 2020
- Macrophage subsets in atherosclerosis as defined by single‐cell technologiesThe Journal of Pathology, 2020
- Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent MannerCell, 2019
- SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr type 1 diabetic miceAtherosclerosis, 2018
- Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of AtherosclerosisCell Metabolism, 2013
- Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy peopleClinical and Experimental Medicine, 2005
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992